DexCom, Inc. (DXCM)
73.78
+0.70
(+0.96%)
USD |
NASDAQ |
Feb 23, 10:10
DexCom Research and Development Expense (Quarterly) : 148.20M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| BioLife Solutions, Inc. | 2.709M |
| Abbott Laboratories | 721.00M |
| Krystal Biotech, Inc. | 13.23M |
| Boston Scientific Corp. | 569.00M |
| Insulet Corp. | 90.90M |